1615-94-7|Simiarenol - Shanghai Canbi Pharma Ltd.

Current Location
Home Products
detail

Simiarenol | CAS:1615-94-7

Simiarenol

Name：Simiarenol
CAS：1615-94-7
Synonyms：
Molecular Formula：C₃₀H₅₀O
Molecular Weight：426.73
EINESC：

Description

Properties

没有数据	没有数据

Safety

没有数据	没有数据

SDS

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

Name	CAS

Articles

Peer-Reviewed Papers

Drug design, in vitro pharmacology, and structure-activity relationships of 3-acylamino-2-aminopropionic acid derivatives, a novel class of partial agonists at the glycine site on the N-methyl-D-aspartate (NMDA) receptor complex.Stephan Urwyler et al.Journal of medicinal chemistry, 52(16), 5093-5107 (2009-08-01) Metabolism of allylglycine and cis-crotylglycine by Pseudomonas putida (arvilla) mt-2 harboring a TOL plasmid.D A Kunz et al.Journal of bacteriology, 148(1), 72-82 (1981-10-01) Disruption of GABAergic tone in the dorsomedial hypothalamus attenuates responses in a subset of serotonergic neurons in the dorsal raphe nucleus following lactate-induced panic.Pl Johnson et al.Journal of psychopharmacology (Oxford, England), 22(6), 642-652 (2008-03-01) Cyclic opioid peptide agonists and antagonists obtained via ring-closing metathesis.Irena Berezowska et al.Chemical biology & drug design, 74(4), 329-334 (2009-08-22) In vivo neurochemical evidence that newly synthesised GABA activates GABA(B), but not GABA(A), receptors on dopaminergic nerve endings in the nucleus accumbens of freely moving rats.Tadashi Saigusa et al.Neuropharmacology, 62(2), 907-913 (2011-10-04)

Remarks

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Name	CAS

Description

Properties

Safety

SDS

Related Products

Related News